Bhoomi Medicaments Profile
Key Indicators
- Authorised Capital ₹ 2.00 Cr
as on 08-12-2024
- Paid Up Capital ₹ 1.22 Cr
as on 08-12-2024
- Company Age 28 Year, 11 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 2.00 M
as on 08-12-2024
- Revenue -10.96%
(FY 2022)
- Profit -59.29%
(FY 2022)
- Ebitda -83.49%
(FY 2022)
- Net Worth 3.15%
(FY 2022)
- Total Assets 1.20%
(FY 2022)
About Bhoomi Medicaments
The Corporate was formerly known as Real Care Pharmaceuticals Limited. The Company is engaged in the Food And Beverages Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 2.00 Cr and a paid-up capital of Rs 1.22 Cr.
The company currently has active open charges totaling ₹2.00 M.
Pradeep Agrawal, Samir Chakraborty, Sunita Agrawal, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24232GJ1996PLC028568
- Company No.
028568
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
05 Jan 1996
- Date of AGM
30 Sep 2024
- Date of Balance Sheet
31 Mar 2024
- Listing Status
Unlisted
- ROC Code
Roc Ahmedabad
Industry
Company Details
- Location
Vadodara, Gujarat, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Bhoomi Medicaments?
Executive Team (1)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Pradeep Agrawal  | Managing Director | 05-Nov-2008 | Current |
Board Members(4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
| Sankalp Agrawal | Director | 06-Jan-2015 | Current |
| Samir Chakraborty | Director | 06-Jan-2015 | Current |
| Sunita Agrawal | Director | 18-Oct-2018 | Current |
| Sudip Chakraborty | Director | 06-Jan-2015 | Current |
Financial Performance and Corporate Structure Insights of Bhoomi Medicaments.
Bhoomi Medicaments Limited, for the financial year ended 2022, experienced significant reduction in revenue, with a 10.96% decrease. The company also saw a substantial fall in profitability, with a 59.29% decrease in profit. The company's net worth moved up by a moderate rise of 3.15%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
| ||||||
| Revenue from Operations |
| ||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Bhoomi Medicaments?
In 2018, Bhoomi Medicaments had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Vital Care Pvt LtdActive 32 years 20 daysPradeep Agrawal, Samir Chakraborty and 3 more are mutual person
Shine Pharmaceuticals LimitedActive 30 years 4 monthsPradeep Agrawal and Samir Chakraborty are mutual person
Interpharm Biotech Private LimitedActive 25 years 2 monthsPradeep Agrawal, Samir Chakraborty and 3 more are mutual person
- Vadodara City Police Parivaar Kalyan FoundationActive 2 years 10 months
Pradeep Agrawal is a mutual person
Charges (Loans)
| Lender | Amount | Status |
|---|---|---|
The Baroda Peoples Co-Op Bank Ltd Creation Date: 08 Jan 2001 | ₹2.00 M | Open |
How Many Employees Work at Bhoomi Medicaments?
Unlock and access historical data on people associated with Bhoomi Medicaments, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Bhoomi Medicaments, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Bhoomi Medicaments's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
